share_log
Reuters ·  2024/09/05 20:30

Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Lymphir™ (Denileukin Diftitox-Cxdl) Added to National Comprehensive Cancer Network (Nccn) Clinical Practice Guidelines in Oncology

Citius Pharmaceuticals, Inc.和Citius Oncology, Inc.宣布Lymphir™ (Denileukin Diftitox-Cxdl)被添加到国家综合癌症网络(NCCN)肿瘤临床实践指南

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发